{
    "SPADE_N_06559": {
        "Clinical Information": [],
        "Patent Information": [],
        "Sequence Information": {
            "SPADE ID": "SPADE_N_06559",
            "Peptide Name": "Brevilaterin B",
            "Source": "Brevibacillus laterosporus",
            "Family": "",
            "Gene": "Not found",
            "Sequence": "XXMXIVVKVLKYLX",
            "Sequence Length": 14,
            "UniProt Entry": [
                "http://www.uniprot.org/uniprot/Notavailable"
            ],
            "Protein Existence": "Not found",
            "Biological Activity": [
                "Antimicrobial",
                "Anticancer"
            ],
            "Target Organism": "Tumor cells:HT-29 (IC50=1.40±0.09 µg/mL); SW1990 (IC50=13.40±0.08 µg/mL); SMMC-7721 (IC50=13.81±0.31 µg/mL); SW480 (IC50=17.15±0.97 µg/mL); EC109 (IC50=2.13±0.23 µg/mL); A498 (IC50=2.33±0.49 µg/mL); DU145 (IC50=2.56±0.23 µg/mL); HeLa (IC50=2.60±0.24 µg/mL); A431 (IC50=2.75±0.07 µg/mL); PANC-1 (IC50=3.11±0.49 µg/mL); KB (IC50=3.14±0.07 µg/mL); HeLa S3 (IC50=3.16±0.45 µg/mL); EC9706 (IC50=3.23±0.16 µg/mL); A-375 (IC50=4.16±0.15 µg/mL); MDA-MB-231 (IC50=4.16±0.27 µg/mL); SK-OV-3 (IC50=4.26±0.25 µg/mL); MCF-7 (IC50=4.94±0.28 µg/mL); A549 (IC50=5.54±0.55 µg/mL); BGC-823 (IC50=5.68±0.25 µg/mL); SGC-7901 (IC50=5.73±0.21 µg/mL); Tca8113 (IC50=5.82±0.25 µg/mL); K562 (IC50=5.86±0.66 µg/mL); PC-3M (IC50=6.17±0.24 µg/mL); A2780 (IC50=7.40±0.36 µg/mL); HCT 116 (IC50=7.67±0.57 µg/mL); Hep-G2 (IC50=9.84±0.39 µg/mL)",
            "Hemolytic Activity": "Not available",
            "Cytotoxicity": "Human Splenic Fibroblasts (HSF):IC50=12.78±0.33 µg/mL; Endometrial epithelial cells(HEEC):IC50=2.66±0.34 µg/mL; HPDE6c7 Human Pancreatic Duct Epithelial Cell:IC50=3.45±0.20 µg/mL; Normal Human Hepatic Cell (Lo-2):IC50=2.91±0.07 µg/mL; NCM460:IC50=3.04±0.10 µg/mL; CCD-19Lu:IC50=4.76±0.03 µg/mL; Human Intrahepatic Biliary Epithelial Cells (HIBEpiC):IC50=2.37±0.38 µg/; HEK293:IC50=4.78±0.32 µg/mL; IOSE80:IC50=1.12±0.04 µg/mL; RWPE-1:IC50=1.07±0.34 µg/mL; GES-1:IC50=10.62±0.73 µg/mL; MCF-10A:IC50=1.58±0.33 µg/mL;",
            "Binding Target": "Not available",
            "Linear/Cyclic": "Linear",
            "N-terminal Modification": "Free",
            "C-terminal Modification": "Free",
            "Stereochemistry": "L",
            "Structure Description": "Not found",
            "Formula": "C59H96N12O8S",
            "Mass": 180561,
            "PI": 10.25,
            "Net Charge": 2,
            "Hydrophobicity": 1.25,
            "Half Life": "Mammalian:/Yeast:/E.coli:/",
            "Literature": [
                {
                    "Title": "Brevilaterin B from Brevibacillus laterosporus has selective antitumor activity and induces apoptosis in epidermal cancer",
                    "Pubmed ID": "Not available",
                    "Reference": "",
                    "Author": "",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=Not available"
                }
            ],
            "Frequent Amino Acids": "XVK",
            "Absent Amino Acids": "ACDEFGHNOPQRSTUW",
            "Basic Residues": 2,
            "Acidic Residues": 0,
            "Hydrophobic Residues": 8,
            "Polar Residues": 6,
            "Positive Residues": 2,
            "Negative Residues": 0,
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_N_15039",
                    "Similarity": 1.0,
                    "Sequence": "MIVVKVLKYL"
                },
                {
                    "SPADE_ID": "SPADE_UN_13954",
                    "Similarity": 1.0,
                    "Sequence": "TNWLWYIKIFIMIV"
                },
                {
                    "SPADE_ID": "SPADE_UN_24611",
                    "Similarity": 1.0,
                    "Sequence": "KVLVKYLGGLLKLAALMV"
                }
            ]
        }
    }
}